India to Turkey: Temozolomide Export Trade Route
India has recorded 59 verified shipments of Temozolomide exported to Turkey, representing a combined trade value of $585.6K USD. This corridor is served by 10 active Indian exporters, with an average shipment value of $9.9K USD. The leading Indian exporter is RELIANCE LIFE SCIENCES PRIVATE LIMITED, which accounts for 97% of total export value with 18 shipments worth $566.5K USD. On the buying side, DEM PHARMACEUTICALS is the largest importer in Turkey with $471.2K USD in purchases. The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED , RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED — together control 98% of total trade value on this route. All data sourced from Indian Customs (DGFT) shipping bill records. Values reported in FOB USD.
Route Intelligence Overview
The India to Turkey Temozolomide corridor is one of India's established pharmaceutical export routes, with 59 shipments documented worth a combined $585.6K USD. The route is dominated by RELIANCE LIFE SCIENCES PRIVATE LIMITED, which alone accounts for roughly 97% of all export value, reflecting the consolidated nature of India's temozolomide manufacturing sector.
Across 10 active suppliers, the average shipment value stands at $9.9K USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 80% of all shipments, consistent with temozolomide's non-urgent bulk-order profile.
Shipment activity peaks during October–December, with an average transit time of 23 days port-to-port. The route has recorded an annual growth rate of 31.2%, placing it at rank #1 among India's top temozolomide export destinations globally.
On the import side, key buyers of Indian temozolomide in Turkey include DEM PHARMACEUTICALS, DEM PHARMACEUTICALS DEM ILAC DEM PLAZA INONU MAH, AL HASEM OTOMOTIV TICARET LIMITED S and 14 others. DEM PHARMACEUTICALS is the single largest importer with 15 shipments valued at $471.2K USD.
Route Characteristics
- Average transit23 days
- Peak seasonQ4
- Primary modeSea freight
- Top portSAHAR AIR CARGO ACC (INBOM4)
Market Position
- Global rank#1
- Annual growth+31.2%
- Demand growth+26.0%
- Regulatory ease84/100
Top 10 Indian Temozolomide Exporters to Turkey
Showing top 10 of 10 Indian suppliers exporting Temozolomide to Turkey, ranked by total trade value (USD)
| Rank | Supplier (Indian Exporter) | Shipments | Total Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | RELIANCE LIFE SCIENCES PRIVATE LIMITED Avg $31.5K per shipment | 18 | $566.5K | 96.7% |
| 2 | RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED Avg $912 per shipment | 5 | $4.6K | 0.8% |
| 3 | RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED Avg $1.0K per shipment | 4 | $4.2K | 0.7% |
| 4 | AMARI TRADE ALLIANCE LLP Avg $430 per shipment | 8 | $3.4K | 0.6% |
| 5 | ROYAL MEDICAL PRIVATE LIMITED Avg $280 per shipment | 12 | $3.4K | 0.6% |
| 6 | ROYAL MEDICAL PRIVATE LIMITED Avg $367 per shipment | 4 | $1.5K | 0.3% |
| 7 | HEET HEALTHCARE PRIVATE LIMITED Avg $762 per shipment | 1 | $762 | 0.1% |
| 8 | RIZLIFE HEALTHCARE Avg $207 per shipment | 3 | $621 | 0.1% |
| 9 | RMPL PHARMA LLP Avg $119 per shipment | 3 | $358 | 0.1% |
| 10 | RMPL PHARMA LLP Avg $354 per shipment | 1 | $354 | 0.1% |
This table shows the top 10 of 10 Indian companies exporting temozolomide to Turkey, ranked by total trade value. The listed exporters are: RELIANCE LIFE SCIENCES PRIVATE LIMITED, RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED , RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED, AMARI TRADE ALLIANCE LLP, ROYAL MEDICAL PRIVATE LIMITED, ROYAL MEDICAL PRIVATE LIMITED , HEET HEALTHCARE PRIVATE LIMITED, RIZLIFE HEALTHCARE , RMPL PHARMA LLP, RMPL PHARMA LLP . RELIANCE LIFE SCIENCES PRIVATE LIMITED is the dominant supplier with 18 shipments worth $566.5K USD, giving it a 97% market share. The top 3 suppliers together account for 98% of the total trade value on this route.
Top 10 Temozolomide Importers in Turkey
Showing top 10 of 17 known buyers in Turkey receiving Temozolomide shipments from India, ranked by import value
On the receiving end of this trade route, the leading importers of Indian temozolomide in Turkey include DEM PHARMACEUTICALS, DEM PHARMACEUTICALS DEM ILAC DEM PLAZA INONU MAH, AL HASEM OTOMOTIV TICARET LIMITED S , AL HASEM OTOMOTIV TICARET LIMITED S, IMPORT PARTY CODE 1051, among 17 total buyers. The largest importer is DEM PHARMACEUTICALS, accounting for $471.2K USD across 15 shipments — representing 80% of all temozolomide imports from India on this route.
| Rank | Importer / Buyer | Shipments | Import Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | DEM PHARMACEUTICALS | 15 | $471.2K | 80.5% |
| 2 | DEM PHARMACEUTICALS DEM ILAC DEM PLAZA INONU MAH | 3 | $95.3K | 16.3% |
| 3 | AL HASEM OTOMOTIV TICARET LIMITED S | 5 | $4.6K | 0.8% |
| 4 | AL HASEM OTOMOTIV TICARET LIMITED S | 4 | $4.2K | 0.7% |
| 5 | IMPORT PARTY CODE 1051 | 2 | $1.9K | 0.3% |
| 6 | NA | 4 | $1.6K | 0.3% |
| 7 | TO THE ORDER OF INVOICE RAISED TO | 3 | $1.2K | 0.2% |
| 8 | TO THE ORDER OF INVOICE RAISED TO | 2 | $945 | 0.2% |
| 9 | To The Order of | 6 | $916 | 0.2% |
| 10 | IMPORT PARTY CODE 1019 | 2 | $892 | 0.2% |
Showing top 10 of 17 Temozolomide importers in Turkey on this route.
Top 10 Temozolomide Formulations Imported by Turkey
Showing top 10 of 43 product formulations shipped on the India to Turkey Temozolomide route, ranked by trade value
Turkey imports a wide range of temozolomide formulations from India, spanning tablets, capsules, suspensions, and combination drugs. The top formulation — TEMOZOLID 100 MG TEMOZOLOMIDE 100 mg — accounts for $124.3K USD across 2 shipments. There are 43 distinct product descriptions in the dataset, reflecting the variety of dosage forms and strengths imported.
| Rank | Product Formulation | Shipments | Trade Value (USD) | Market Share |
|---|---|---|---|---|
| 1 | TEMOZOLID 100 MG TEMOZOLOMIDE 100 mg | 2 | $124.3K | 21.2% |
| 2 | TEMOZOLID 100 MG TEMOZOLOMIDE 100 MGNOS | 1 | $65.9K | 11.3% |
| 3 | TEMOZOLID 100 MG TEMOZOLOMIDE 100 MG | 1 | $65.5K | 11.2% |
| 4 | TEMOZOLOMIDE 100MG (TEMOZOLID 100MG) | 1 | $65.1K | 11.1% |
| 5 | TEMOZOLID 100MG TEMOZOLOMIDE 100MG | 1 | $57.1K | 9.8% |
| 6 | TEMOZOLID 250 MG TEMOZOLOMIDE 250 mg | 2 | $46.4K | 7.9% |
| 7 | TEMOZOLID 250MG TEMOZOLOMIDE 250MG | 1 | $24.5K | 4.2% |
| 8 | TEMOZOLID 250 MG TEMOZOLOMIDE 250 MGNOS | 1 | $21.5K | 3.7% |
| 9 | TEMOZOLID 250 MG TEMOZOLOMIDE 250 MG | 1 | $21.3K | 3.6% |
| 10 | TEMOZOLOMIDE 250MG (TEMOZOLID 250MG) | 1 | $21.2K | 3.6% |
Showing top 10 of 43 Temozolomide formulations imported by Turkey on this route.
Shipping & Logistics Analysis
Freight mode split and port-of-origin breakdown
Freight Mode Distribution
Sea freight dominates at 80%, typical for bulk pharmaceutical shipments.
Top Ports of Origin
SAHAR AIR CARGO ACC (INBOM4) handles the highest volume with 22 shipments. Transit time averages 23 days by sea.
Market Dynamics
India's temozolomide exports to Turkey are driven primarily by a handful of large-scale manufacturers. RELIANCE LIFE SCIENCES PRIVATE LIMITED with 18 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 10 active exporters signals a competitive but concentrated market — buyers in Turkey benefit from supplier diversity while the top tier handles the majority of volume.
The top 3 suppliers — RELIANCE LIFE SCIENCES PRIVATE LIMITED, RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED , RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED — together account for 98% of total trade value on this route. The average shipment value of $9.9K USD reflects a mix of bulk commercial orders and smaller specialty shipments.
Beyond the primary product category, shipments on this route include closely related formulations such as temozolid 100 mg temozolomide 100 mgnos and temozolid 100 mg temozolomide 100 mg, suggesting that buyers in Turkey tend to consolidate orders across related product lines from the same Indian supplier.
On the buying side, DEM PHARMACEUTICALS is the largest importer with 15 shipments worth $471.2K USD — representing 80% of all temozolomide imports from India on this route. A total of 17 buyers are active on this corridor.
Route Statistics
- Trade Volume
- $585.6K
- Avg. Shipment
- $9.9K
- Suppliers
- 10
- Buyers
- 17
- Transit (Sea)
- ~23 days
- Annual Growth
- +31.2%
Related Analysis
Other Temozolomide Routes
Unlock the Full India to Turkey Temozolomide Dataset
TransData Nexus provides verified shipment-level records, supplier contact details, HS code breakdowns, real-time pricing benchmarks, and regulatory compliance guides for 59 shipments on this route.
Frequently Asked Questions — India to Turkey Temozolomide Trade
Answers based on Indian Customs (DGFT) shipment records compiled by TransData Nexus
Q Which Indian companies export Temozolomide to Turkey?
The leading Indian exporters of Temozolomide to Turkey are RELIANCE LIFE SCIENCES PRIVATE LIMITED, RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED , RAWIA INTERNATIONAL HEALTHCARE PRIVATE LIMITED. RELIANCE LIFE SCIENCES PRIVATE LIMITED holds the largest market share at approximately 97% of total trade value on this route.
Q What is the total value of Temozolomide exports from India to Turkey?
India exports Temozolomide to Turkey worth approximately $585.6K USD across 59 recorded shipments. The average value per shipment is $9.9K USD.
Q Which ports does India use to ship Temozolomide to Turkey?
The most active port of origin is SAHAR AIR CARGO ACC (INBOM4) with 22 shipments. Indian exporters primarily use sea freight for this route, with 80% of shipments going by sea and 27% by air.
Q How long does shipping take from India to Turkey for Temozolomide?
The average transit time for Temozolomide shipments from India to Turkey is approximately 23 days. Sea freight typically takes longer, while air freight can reduce this significantly for urgent orders. Peak shipping activity is observed during October–December.
Q Is the India to Turkey Temozolomide trade route growing?
Yes — this trade corridor has seen an annual growth rate of approximately 31.2% with demand growth tracking at 26.0%. The route is ranked #1 among India's top Temozolomide export destinations globally.
Q How many suppliers are active on the India to Turkey Temozolomide route?
There are currently 10 active Indian suppliers exporting Temozolomide to Turkey. The market is moderately concentrated with RELIANCE LIFE SCIENCES PRIVATE LIMITED accounting for 97% of total shipment value.
Q Who are the main importers of Temozolomide from India in Turkey?
The leading importers of Indian Temozolomide in Turkey include DEM PHARMACEUTICALS, DEM PHARMACEUTICALS DEM ILAC DEM PLAZA INONU MAH, AL HASEM OTOMOTIV TICARET LIMITED S , AL HASEM OTOMOTIV TICARET LIMITED S, IMPORT PARTY CODE 1051. DEM PHARMACEUTICALS is the largest buyer with 15 shipments worth $471.2K USD.
Official References & Regulatory Resources
- India Trade Statistics (DGFT)
- Invest India — Pharma Sector
- WCO HS Nomenclature
- Ministry of Commerce — Pharma Exports
- Pharmexcil
Data sourced from Indian Customs (DGFT) records. Verify regulatory and trade status with the agencies above.
Research Methodology & Data Transparency
Suresh Sormare
Verified AuthorPharmaceutical Export-Import Analyst & Trade Intelligence Expert
Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.
linkedin.com/in/sureshsormarePrimary Data Source
All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.
Analysis Methodology
- 1.Route Identification: India to Turkey export trade corridor identified from Indian Customs (DGFT) records for Temozolomide.
- 2.Supplier/Buyer Matching: 10 Indian exporters and 17 importers in Turkey matched using name normalization.
- 3.Value Aggregation: Total export value aggregated from 59 verified shipping bill records. Values are FOB in USD.
- 4.Market Share Analysis: Each supplier and buyer contribution calculated as a percentage of total route value. Statistical normalization applied to ensure accurate representation across varying shipment sizes.
Government-Sourced Data
Official DGFT customs records
Transparent Methodology
Calculations fully disclosed above
59 Verified Shipments
10 Indian exporters tracked
Expert-Reviewed
By pharmaceutical trade specialists